CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Scope Biosciences has developed a CRISPR-Cas diagnostic technology called scopeDx, which combines the speed of isothermal amplification with the accuracy of PCR. This platform aims to provide rapid, portable, and cost-effective diagnostic results for various pathogens at the point of care.
In the healthcare sector, rapid and precise point-of-care diagnostics is indispensable for enhancing patient outcomes, particularly in critical scenarios such as sepsis and organ transplantations.
Present In Vitro Diagnostic technologies often strike a compromise between accuracy, speed, portability, and cost-effectiveness.
Immunoassays offer rapidity but sacrifice accuracy, while molecular diagnostics like PCR deliver accuracy at the expense of time and ease of use.
Isothermal molecular tests,…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
